Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Malgorzata, Dylewska"'
Autor:
Joanna, Listos, Sylwia, Talarek, Magdalena, Gryzinska, Piotr, Listos, Ewa, Kedzierska, Jolanta, Orzelska-Gorka, Malgorzata, Dylewska, Malgorzata, Lupina, Kotlinska, Jolanta H.
Publikováno v:
In European Journal of Pharmacology 5 September 2017 810:63-69
Autor:
Irene Y. Chong, Christopher J. Lord, Wojciech Niedzwiedz, Syed Haider, Andres Cervantes, Johann de Bono, Stephen J. Pettitt, Jyoti Choudhary, Theodoros Roumeliotis, Ana Ferreira, Ruth Riisnaes, Bora Gurel, Frank T. Zenke, Astrid Zimmermann, Rachel Brough, Ronan Broderick, Malgorzata Dylewska, Feifei Song, John Alexander, Jadwiga Nieminuszczy, Dragomir B. Krastev, Lauren I. Aronson, Marta J. Llorca-Cardenosa
Supplementary Data from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1587dcc4a0be2c2d50162b142e37df4
https://doi.org/10.1158/0008-5472.22433013
https://doi.org/10.1158/0008-5472.22433013
Autor:
Irene Y. Chong, Christopher J. Lord, Wojciech Niedzwiedz, Syed Haider, Andres Cervantes, Johann de Bono, Stephen J. Pettitt, Jyoti Choudhary, Theodoros Roumeliotis, Ana Ferreira, Ruth Riisnaes, Bora Gurel, Frank T. Zenke, Astrid Zimmermann, Rachel Brough, Ronan Broderick, Malgorzata Dylewska, Feifei Song, John Alexander, Jadwiga Nieminuszczy, Dragomir B. Krastev, Lauren I. Aronson, Marta J. Llorca-Cardenosa
Gastric cancer represents the third leading cause of global cancer mortality and an area of unmet clinical need. Drugs that target the DNA damage response, including ATR inhibitors (ATRi), have been proposed as novel targeted agents in gastric cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e563c09a484cf966f330a341b09c73e
https://doi.org/10.1158/0008-5472.c.6514290.v1
https://doi.org/10.1158/0008-5472.c.6514290.v1
Autor:
Irene Y. Chong, Christopher J. Lord, Wojciech Niedzwiedz, Syed Haider, Andres Cervantes, Johann de Bono, Stephen J. Pettitt, Jyoti Choudhary, Theodoros Roumeliotis, Ana Ferreira, Ruth Riisnaes, Bora Gurel, Frank T. Zenke, Astrid Zimmermann, Rachel Brough, Ronan Broderick, Malgorzata Dylewska, Feifei Song, John Alexander, Jadwiga Nieminuszczy, Dragomir B. Krastev, Lauren I. Aronson, Marta J. Llorca-Cardenosa
Supplementary Table from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e7bde9d3ff1abb9ef60efb2134cb7ae
https://doi.org/10.1158/0008-5472.22433010
https://doi.org/10.1158/0008-5472.22433010
Autor:
Charlotte Hodson, Sylvie van Twest, Malgorzata Dylewska, Julienne J. O’Rourke, Winnie Tan, Vincent J. Murphy, Mannu Walia, Lara Abbouche, Jadwiga Nieminuszczy, Elyse Dunn, Rohan Bythell-Douglas, Jörg Heierhorst, Wojciech Niedzwiedz, Andrew J. Deans
Publikováno v:
Cell reports. 41(10)
Co-transcriptional R loops arise from stalling of RNA polymerase, leading to the formation of stable DNA:RNA hybrids. Unresolved R loops promote genome instability but are counteracted by helicases and nucleases. Here, we show that branchpoint transl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae97797a3dec73f8f151b8bae540e23e
https://pubmed.ncbi.nlm.nih.gov/36476850
https://pubmed.ncbi.nlm.nih.gov/36476850
Autor:
Marta J. Llorca-Cardenosa, Lauren I. Aronson, Dragomir B. Krastev, Jadwiga Nieminuszczy, John Alexander, Feifei Song, Malgorzata Dylewska, Ronan Broderick, Rachel Brough, Astrid Zimmermann, Frank T. Zenke, Bora Gurel, Ruth Riisnaes, Ana Ferreira, Theodoros Roumeliotis, Jyoti Choudhary, Stephen J. Pettitt, Johann de Bono, Andres Cervantes, Syed Haider, Wojciech Niedzwiedz, Christopher J. Lord, Irene Y. Chong
Publikováno v:
CANCER RESEARCH
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Gastric cancer represents the third leading cause of global cancer mortality and an area of unmet clinical need. Drugs that target the DNA damage response, including ATR inhibitors (ATRi), have been proposed as novel targeted agents in gastric cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4314d3a129d8fa93630be84dbe207ba
https://pubmed.ncbi.nlm.nih.gov/36273494
https://pubmed.ncbi.nlm.nih.gov/36273494